Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
The Woodlands, TX
SEC filing record 1 source field available
Fiscal year end
31 December
LEXICON PHARMACEUTICALS, INC. has filed 1,396 SEC EDGAR filings since 09 Feb 2000

SEC filing history

Showing 676-700 of 994 matching filings.

Per page
25
Current page
28
SC 13G/A File 005-60409

SC 13G/A filing

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K

Filing date
22 Jan 2016
Reporting date
21 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-30111

CT ORDER filing

Filing date
18 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K (2015Q3EARNINGS)

Filing date
06 Nov 2015
Reporting date
06 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

FORM 8-K

Filing date
06 Nov 2015
Reporting date
05 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60409

SC 13G/A filing

Filing date
14 Oct 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-60409

SC 13G filing

Filing date
14 Oct 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-30111

CT ORDER filing

Filing date
25 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K

Filing date
07 Aug 2015
Reporting date
07 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K

Filing date
22 May 2015
Reporting date
22 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K

Filing date
29 Apr 2015
Reporting date
29 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Apr 2015
Reporting date
24 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Apr 2015
Reporting date
24 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Apr 2015
Reporting date
24 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Apr 2015
Reporting date
24 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Apr 2015
Reporting date
24 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Apr 2015
Reporting date
24 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Apr 2015
Reporting date
24 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Apr 2015
Reporting date
24 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

FORM 8-K (2015 ANNUAL MEETING)

Filing date
23 Apr 2015
Reporting date
23 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K IPSEN AMENDMENT

Filing date
18 Mar 2015
Reporting date
18 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-30111

AUTO-GENERATED PAPER DOCUMENT

Filing date
16 Mar 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .